Celldex Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $712k | 21k | 33.99 |
| 2024-06-30 | $5.2M | 139k | 37.01 |
| 2024-03-31 | $3.8M | 91k | 41.97 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management